India’s Serum Institute overpromises and underdelivers as Covid death toll mounts
The Serum Institute of India’s travails are a key illustration of how the effort to inoculate against Covid-19 has failed the developing world
London/New Delhi —Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programmes as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.
The world’s largest vaccine maker, Serum was named a top supplier of Covid-19 shots to Covax in 2020, the World Health Organisation-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, which have hampered its ability to fill orders...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.